Artificial Organ and Bionics Market Size, Share and Forecast to 2031

Bionic implants and artificial organs are externally worn or implantable engineered medical devices manufactured artificially. An artificial organ is a man-made device or tissue implanted or integrated into a person — interacting with living tissue — to substitute a natural organ, replicate or augment a specific function, and allow the patient to return to normal life as soon as possible. The substituted function is not required to be linked to life support, although it often is.

For example, artificial organs could consist of replacement bones and joints, such as those used in hip replacements. Bionics, also called biologically inspired engineering, studies and develops engineering systems and modern technology based on biological principles and natural systems. Implantable devices that contain mechanical and electrical components are called bionic implants. They can be categorized into two types: mechanical and electronic.

Market Dynamics

Increasing Incidence of Organ Failure Drives the Global Market

Severe trauma, sepsis, blood loss, poisoning, drug addiction, leukemia, and other acute illnesses all contribute to the increase in the incidence of organ failure. Acute illnesses resulting from organ degeneration or injury are associated with organ failure. Glomerular disease, diabetes, and hypertensive nephrosclerosis can lead to renal failure. Typically, unhealthy eating habits, lack of exercise, alcohol and substance abuse, and other behaviors, such as smoking, contribute to conditions that ultimately result in organ failure. Therefore, the global demand for artificial organs, primarily bone marrow, heart, liver, kidney, and lung, is very high.

In addition to an increase in the elderly population and well-established healthcare facilities, the high demand for artificial organs has also been fueled by an increase in the number of people requiring transplants. Thus, a rise in acute ailments and an increase in the elderly population are expected to increase the demand for organ transplantation, driving market growth.

Technological Advancement in Transplantation Methods Creates Tremendous Opportunities

The persistent organ donor scarcity and the growing number of patients awaiting transplants have increased the demand for 3D bioprinting. These techniques produce customized prosthetics, construct tissues, and facilitate transplantation using synthetic models. However, vascularizing larger tissue structures continues to be challenging, and the development of a fully functional 3D-printed organ is envisaged within the next few years. In addition, inadequate organ preservation facilities contribute to the increased demand for artificial organs. Organ preservation is of the utmost importance during transplantation surgery. Organ preservation serves as a source of organs for transplantation. The optimal method for utilizing the preserved organ relies on hypothermia to inhibit metabolism. Therefore, these developments in organ transplantation create opportunities for market expansion.

Regional Analysis

North America is the most significant global artificial organ and bionics market shareholder and is estimated to exhibit a CAGR of 10.51% during the forecast period. North America held the largest share of the artificial organ and bionics market due to increased organ transplantation procedures and a rise in demand for organ transplants because of the high incidence of organ failures. According to the Organ Procurement and Transplantation Network, 118,020 Americans required organ transplants in 2017. The incidence of organ failure has increased alongside the prevalence of chronic diseases like cancer, kidney disease, and cardiovascular disease. This has resulted in high demand for artificial organs, encouraging further research. In addition, the increase in transplant centers in the United States and Canada has increased the demand for artificial organs and bionics. According to the Transplant Observatory, 2,490 organ transplants, including 1,437 kidney transplants and 526 liver transplants, were performed in Canada.

Asia-Pacific is estimated to exhibit a CAGR of 11.3% over the forecast period. The Asia-Pacific region includes several emerging economies, including Japan, China, and India. These nations have substantial populations and a high prevalence of chronic diseases. In the coming years, an increase in chronic diseases contributing to organ failure is anticipated to increase the demand for transplants in this region. Medical tourism is booming because these countries are technologically advanced and provide a wide range of cutting-edge surgical procedures. Due to the region's inexpensive surgical procedures, many foreign patients travel there for medical purposes. Therefore, the growth of the organ and bionics market in the region has been significantly influenced by the increase in medical tourism and the prevalence of chronic diseases that induce organ failure.

Key Highlights

The global artificial organ and bionics market was valued at USD 33.78 billion in 2022. It is estimated to reach USD 75.82 billion by 2031, growing at a CAGR of 9.4% during the forecast period (2023–2031).
Based on product, the global artificial organ and bionics market is bifurcated into artificial organ and bionics. The artificial organ segment dominates the global market and is projected to exhibit a CAGR of 8.7% over the forecast period.
Based on technology, the global artificial organ and bionics market is segmented into mechanical and electronic. The mechanical segment owns the highest market share and is estimated to exhibit a CAGR of 9.1% during the forecast period.
North America is the most significant global artificial organ and bionics market shareholder and is estimated to exhibit a CAGR of 10.51% during the forecast period.